Form 4: Arteris COO Files Future Stock Sale Under Pre-Planned 10b5-1 Program

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, has filed a Form 4 disclosing a planned sale of 736 common shares on July 29, 2025, under a pre-established 10b5-1 trading plan.

Summary

• Laurent R. Moll, Chief Operating Officer of Arteris, Inc. (AIP), reported a planned disposition of 736 shares of common stock.
• The transaction is scheduled to occur on July 29, 2025, at a price of $10.9 per share.
• This sale is being conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Moll on March 12, 2025.
• Following this planned transaction, Mr. Moll will beneficially own 476,471 shares of Arteris, Inc. common stock.

Sentiment

Score: 5

Explanation: The filing reports a pre-planned insider stock sale, which is a routine event under a 10b5-1 plan. The quantity of shares sold is relatively small compared to total holdings, suggesting a neutral impact on overall sentiment.

Negatives

• A sale of shares by a Chief Operating Officer, even if pre-planned, can sometimes be perceived as a slight negative signal regarding insider sentiment, though the quantity is relatively small.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, which is generally not a significant concern given it's a pre-planned transaction and a small percentage of total holdings.

Key Dates

Keywords

Arteris Inc., AIP, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Chief Operating Officer, Common Stock